Lindkær-Jensen, S., Larsen, S., Habib-Lindkær-Jensen, N., & Fagertun, H. E. (2015). Positive effects on hematological and biochemical imbalances in patients with metastatic breast cancer stage IV, of BP-C1, a new anticancer substance. Drug Des Devel Ther.
Citación estilo ChicagoLindkær-Jensen, Steen, Stig Larsen, Nina Habib-Lindkær-Jensen, y Hans E. Fagertun. "Positive Effects On Hematological and Biochemical Imbalances in Patients With Metastatic Breast Cancer Stage IV, of BP-C1, a New Anticancer Substance." Drug Des Devel Ther 2015.
Cita MLALindkær-Jensen, Steen, Stig Larsen, Nina Habib-Lindkær-Jensen, y Hans E. Fagertun. "Positive Effects On Hematological and Biochemical Imbalances in Patients With Metastatic Breast Cancer Stage IV, of BP-C1, a New Anticancer Substance." Drug Des Devel Ther 2015.